Neotelmi Tablet 40 mg (Telmisartan)

Adult dose

For essential hypertension, 40 mg of Telmisartan is administered orally once daily with water, and it can be taken regardless of meals. Depending on the patient, 20 mg once daily may also be effective, and if necessary, can be increased up to 80 mg once daily. Maximum blood pressure-lowering effect is typically observed 4 to 8 weeks after treatment initiation. For the reduction of cardiovascular disease risk, it is recommended to take 80 mg orally once daily with water.

This medication may cause serious harm to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Pregnant women or women of childbearing age, and nursing mothers should not take this medication. Patients with severely impaired liver function or problems with bile excretion should also avoid this medication. Patients with hereditary angioedema or a history of angioedema should avoid taking this drug. Patients with diabetes or moderate to severe renal impairment should not use specific medications concurrently. Elderly patients, those with hyperkalemia, and patients with mild to moderate liver impairment should use this medication with caution. Caution is required when administered to patients with valvular heart disease or cardiovascular diseases. Patients with renal artery stenosis or severe renal impairment should consult a physician before taking this medication. This drug lowers blood pressure, occasionally causing dizziness, hypotension, syncope, etc.; therefore, symptoms should be carefully monitored while taking it. Serious adverse reactions such as hyperkalemia, renal function deterioration, liver dysfunction, angioedema, interstitial pneumonia, and rhabdomyolysis may occur, and any unusual symptoms should be reported to medical personnel immediately. This medication may enhance the blood pressure-lowering effect if used with other antihypertensive agents, so it should be taken according to the physician's instructions. In particular, combinations with ACE inhibitors and aliskiren are not recommended due to potential risks. Caution is also required when taken with potassium supplements or potassium-sparing diuretics, as serum potassium levels may rise. It is advisable to discontinue this medication 24 hours before surgery. It is not recommended for children and adolescents under 18 years due to insufficient safety and efficacy established. Caution is advised while driving or operating machinery due to risks of dizziness or syncope. Overdosage may result in hypotension, tachycardia, dizziness, acute renal failure, necessitating immediate medical attention. This medication should be stored out of reach of children and should be opened only prior to use.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, breathing problems, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden

Mild side effects

• Upper respiratory tract infection
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia
• hypoglycemia
• hyponatremia

This drug may be sensitive to air or moisture, so it should be stored in a tightly closed container. The recommended storage temperature is a room temperature between 1 degree and 30 degrees Celsius. This helps maintain the drug's effectiveness for a longer time.

Appearance

White or nearly white, biconvex round tablet

Package unit

10 tablets/blister x 3, 30 tablets/bottle, 100 tablets/bottle